Publication: Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles
Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles
Date
Date
Date
Citations
Schweneker, M., Laimbacher, A. S., Zimmer, G., Wagner, S., Schraner, E. M., Wolferstätter, M., Klingenberg, M., Dirmeier, U., Steigerwald, R., Lauterbach, H., Hochrein, H., Chaplin, P., Suter, M., & Hausmann, J. (2017). Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles. Journal of Virology, 91(11), e00343-17. https://doi.org/10.1128/JVI.00343-17
Abstract
Abstract
Abstract
There are currently no approved therapeutics or vaccines to treat or protect against the severe hemorrhagic fever and death caused by Ebola virus (EBOV). Ebola virus-like particles (EBOV VLPs) consisting of the matrix protein VP40, the glycoprotein (GP), and the nucleoprotein (NP) are highly immunogenic and protective in nonhuman primates against Ebola virus disease (EVD). We have constructed a modified vaccinia virus Ankara-Bavarian Nordic (MVA-BN) recombinant coexpressing VP40 and GP of EBOV Mayinga and the NP of Taï Forest virus (T
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Citations
Schweneker, M., Laimbacher, A. S., Zimmer, G., Wagner, S., Schraner, E. M., Wolferstätter, M., Klingenberg, M., Dirmeier, U., Steigerwald, R., Lauterbach, H., Hochrein, H., Chaplin, P., Suter, M., & Hausmann, J. (2017). Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles. Journal of Virology, 91(11), e00343-17. https://doi.org/10.1128/JVI.00343-17